Currently browsing posts found in January2008
Tocilizumab Appears Safe and Effective in Treating Rheumatoid Arthritis
Number of Comments » 0
Newswise — Phase III testing shows that a potential new therapy called tocilizumab is safe and effective in the treatment of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Rheumatoid arthritis is a chronic disease that causes pain, stiffness, swelling, and limitation in the […]
Being Overweight Could Prevent Your Rheumatoid Arthritis from Going into Remission
Number of Comments » 0Medicine hat news obituaryBeing overweight can prevent sufferers of rheumatoid arthritis from going into remission, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Rheumatoid arthritis is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. Though […]
Promising New Anti-TNF Therapy Therapy Being Studied to Treat Rheumatoid Arthritis
Number of Comments » 0
Newswise — A potential new therapy called certolizumab pegol, when used in combination with methotrexate, may be safe and effective at treating active rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
Rheumatoid arthritis is a chronic disease that causes pain, stiffness, swelling, and […]
Animal Research Uncovers Another Mechanism of Cholesterol Lowering Drug
Number of Comments » 0
Newswise — New research in animals suggests why the commonly prescribed cholesterol-lowering drug ezetimibe (Zetia) is so potent. The research, reported by scientists at Wake Forest University School of Medicine, is reported online today by the Journal of Clinical Investigation and will appear in the July 2 print issue.
It had previously been thought that the […]
Study Yields Secrets of Chromosome Movement
Number of Comments » 0Newswise — Investigators at St. Jude Children’s Research Hospital have used the lowly yeast to gain insights into how a dividing human cell ensures that an identical set of chromosomes gets passed on to each new daughter cell. Errors in this critical part of cell division can cause one daughter cell to get extra copies […]
Does Circumcision Remove the Most Sensitive Parts of the Penis?
Number of Comments » 0
Newswise — The most common medical procedure in the US is infant male news in medicine. The emergency medicine news impact of neo-natal circumcision has received little study while the internal medicine news of circumcision on sexual function in the adult male have received even less attention.
A recent study by M. Sorrels and colleagues […]
Researchers Use ‘Genomic Pathway’ to Predict Parkinson’s
Number of Comments » 0Newswise — A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinsons disease while others dont, and even predict with great accuracy at what age people might develop their first symptoms. […]
Colon Cancer Proteins Show Promise for Blood Test
Number of Comments » 0
Newswise — Searching for less invasive screening tests for cancer, Johns Hopkins scientists have discovered proteins present in blood that accurately identify colon cancer and precancerous polyps.
Initial studies of the proteins, CCSA-3 and CCSA-4, suggest they could be used to develop a blood test to identify at-risk individuals.
“The reality is that many people are not […]
Does OTC Diet Pill Alli Live Up to Its Name?
Number of Comments » 0
Newswise — The first and only over-the-counter product for weight loss approved by the Food and Drug Administration will be available Friday, June 15.
Orlistat, known by the brand name Alli, works by decreasing the amount of fat absorbed by the body. It is the OTC version of Xenical, a prescription weight loss pill. […]
National Toxicology Program Gets New Associate Director
Number of Comments » 0
Newswise — John Bucher, Ph.D., will serve as the new associate director of the National Toxicology Program (NTP), and will begin managing the day-to-day operations of the program on June 18. The NTP is an interagency program with the mission to coordinate, conduct and communicate toxicological research across the U.S. government.
For 29 years, the […]